Large-scale computational study proposing novel hyperparameter scaling laws for sparse models, but lacks peer review, clinical/patient outcomes, and independent validation on held-out test cases beyond one ultra-sparse configuration.
Researcher
3 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
Large-scale computational study proposing novel hyperparameter scaling laws for sparse models, but lacks peer review, clinical/patient outcomes, and independent validation on held-out test cases beyond one ultra-sparse configuration.
SEP 5, 2026 · JOURNAL ARTICLE
Cancer Science
Phase II trial with modest sample size showing acceptable safety profile and 40% response rate for dysphagia in advanced esophageal cancer, but requires larger confirmatory studies before clinical adoption.
AUG 12, 2026 · PREPRINT
arXiv
This is a computational analysis using existing models to examine mechanisms underlying on-policy distillation; it raises questions about the interpretation of OPD rather than providing empirical evidence of clinical or practical utility.